Archynetys Live news trend intelligence
↓ Cooling Business

EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials

A US House committee has launched an investigation into Merck and AbbVie regarding drug trials conducted in China.

8sources
8articles
6velocity
-60%since first seen
7h agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

A US House committee is investigating drug trials in China conducted by Merck and AbbVie. According to Quartz, the investigation centers on trials tied to the Chinese military.

Coverage from Reuters and Endpoints News emphasizes that the House China panel is also questioning other pharmaceutical companies, specifically Bristol Myers and Pfizer, regarding trial sites. Pharmaphorum reports that drugmakers have been asked to defend these trials.

Market reactions are already appearing, with Investing.com Nigeria noting a slip in AbbVie stock. Future developments depend on the outcomes of the House panel's inquiries into these trial sites.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 5h ago.

Quick answers

Which companies are being investigated?

The US House committee has opened an investigation into Merck and AbbVie, while also questioning Bristol Myers and Pfizer.

What is the focus of the investigation?

The investigation concerns drug trials in China, with Quartz reporting links to the Chinese military.

How has the market responded?

Investing.com Nigeria reported that AbbVie stock is slipping today.

Coverage (8)

Topics

Related trends